Positioning filgotinib in the treatment algorithm of moderate to severe ulcerative colitis.

Ferdinando D'AmicoFernando MagroLaurent Peyrin-BirouletSilvio Danese

Published in: Journal of Crohn's & colitis (2021)

Filgotinib is an effective and safe drug for treatment of both biologic-naive and biologic experienced patients with moderate to severe UC and may soon be available.

Keyphrases

rheumatoid arthritis
ulcerative colitis
machine learning
early onset
emergency department
replacement therapy
electronic health record